Doctors Defend Ozempic: Isolated Cases Must Not Stop Liepāja Tram Therapy
While associations protect diabetes medication from scandal, in Liepāja we prove with our tram that one line can be more effective than all of Riga's public transport.
Latvian doctors today stand in defense of the diabetes medication Ozempic, announcing that isolated cases of inappropriate prescribing must not create a misleading impression of the entire therapy. Such logic is not foreign in Liepāja — we have known for years that one good tram can be more effective than the entire Riga public transport fleet combined.
Liepāja Family Doctors Association president Ainis Dzalbs emphasized that GLP-1 receptor agonists are an important drug group that helps control glucose levels and reduce body mass. "It's like with our tram," comments local doctor Kārlis Vējiņš, "one quality line does more than the entire Riga metro planning committee has in the last twenty years."
Particularly piquant is that in Latvia these medications can only be prescribed after an endocrinologist consultation, while in other Baltic countries they are available from family doctors. "We need to simplify the system," says Dzalbs, "not create such bureaucratic queues like in Riga's polyclinics, where patients die faster than they can reach a specialist."
Although some question the proper prescribing of the medication, endocrinologists remind that diabetes is a chronic disease requiring timely treatment. Just like our tram — it has been operating for 120 years and hasn't thought of stopping, while Riga is still discussing the possibility of metro construction.
⚠️ Satirical article. Facts are preserved, but the presentation is humorous. For accurate information, please refer to the original source.